Detection of an activating c-kit mutation by real-time PCR in patients with anaphylaxis - PubMed (original) (raw)
Detection of an activating c-kit mutation by real-time PCR in patients with anaphylaxis
Wendy Lawley et al. Mutat Res. 2005.
Abstract
A well-characterised gain-of-function point mutation within exon 17 of the c-kit proto-oncogene known as Asp816Val is present in patients with mastocytosis. Activation of mast cells through this receptor primes them for IgE-dependent activation, and patients with mastocytosis are at increased risk of anaphylaxis. We hypothesised that the Asp816Val mutation is associated with a history of anaphylaxis in the general population. A mismatch amplification real-time PCR assay was developed and validated to test for the Asp816Val mutation. Subjects were recruited to four subject groups: normal non-atopics, atopics without anaphylaxis, food-induced anaphylactics and non-food anaphylactics. Blood samples collected from forty subjects were tested for the presence of Asp816Val. Thirteen subjects were found to carry the mutation; normals (2/9), atopics (2/10), food anaphylactics (5/11) and non-food anaphylactics (4/10). Statistical analysis of the data determined that there was no significant difference between the numbers of subjects found to carry the Asp816Val mutation in each of the groups although a trend towards an increased occurrence in anaphylactics was observed. In summary, the hypothesis that the presence of the Asp816Val mutation is linked to the occurrence of anaphylaxis was not supported, but interestingly, we have shown for the first time Asp816Val may occur more frequently than previously reported within the general population.
Similar articles
- Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.
Zappulla JP, Dubreuil P, Desbois S, Létard S, Hamouda NB, Daëron M, Delsol G, Arock M, Liblau RS. Zappulla JP, et al. J Exp Med. 2005 Dec 19;202(12):1635-41. doi: 10.1084/jem.20050807. Epub 2005 Dec 13. J Exp Med. 2005. PMID: 16352739 Free PMC article. - Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, Castellani L, Bonetto C, Frattini F, Dama A, Martinelli G, Chilosi M, Senna G, Pizzolo G, Zanotti R. Bonadonna P, et al. J Allergy Clin Immunol. 2009 Mar;123(3):680-6. doi: 10.1016/j.jaci.2008.11.018. Epub 2009 Jan 9. J Allergy Clin Immunol. 2009. PMID: 19135713 - Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.
Akin C, Kirshenbaum AS, Semere T, Worobec AS, Scott LM, Metcalfe DD. Akin C, et al. Exp Hematol. 2000 Feb;28(2):140-7. doi: 10.1016/s0301-472x(99)00145-9. Exp Hematol. 2000. PMID: 10706069 - Recent advances in the understanding of mastocytosis: the role of KIT mutations.
Orfao A, Garcia-Montero AC, Sanchez L, Escribano L; REMA. Orfao A, et al. Br J Haematol. 2007 Jul;138(1):12-30. doi: 10.1111/j.1365-2141.2007.06619.x. Br J Haematol. 2007. PMID: 17555444 Review. - KIT and mastocytosis.
Lim KH, Pardanani A, Tefferi A. Lim KH, et al. Acta Haematol. 2008;119(4):194-8. doi: 10.1159/000140630. Epub 2008 Jun 20. Acta Haematol. 2008. PMID: 18566536 Review.
Cited by
- Detection of clonal mast cell disease in wasp venom allergic patients with normal tryptase.
Onnes MC, Alheraky A, Nawijn MC, Sluijter TE, Mulder AB, Arends S, Oude Elberink HNG. Onnes MC, et al. Clin Transl Allergy. 2022 Sep 7;12(9):e12174. doi: 10.1002/clt2.12174. eCollection 2022 Sep. Clin Transl Allergy. 2022. PMID: 36090584 Free PMC article. - Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.
Molderings GJ, Brettner S, Homann J, Afrin LB. Molderings GJ, et al. J Hematol Oncol. 2011 Mar 22;4:10. doi: 10.1186/1756-8722-4-10. J Hematol Oncol. 2011. PMID: 21418662 Free PMC article. Review. - Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases.
Han L, Schuringa JJ, Mulder A, Vellenga E. Han L, et al. Ann Hematol. 2010 Sep;89(9):861-71. doi: 10.1007/s00277-010-0948-7. Epub 2010 Apr 13. Ann Hematol. 2010. PMID: 20387067 Free PMC article. - Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.
Jensen BM, Akin C, Gilfillan AM. Jensen BM, et al. Br J Pharmacol. 2008 Aug;154(8):1572-82. doi: 10.1038/bjp.2008.204. Epub 2008 May 26. Br J Pharmacol. 2008. PMID: 18500355 Free PMC article. Review. - Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.
Akin C. Akin C. J Mol Diagn. 2006 Sep;8(4):412-9. doi: 10.2353/jmoldx.2006.060022. J Mol Diagn. 2006. PMID: 16931579 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical